{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:20:33Z","timestamp":1684642833641},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41435-018-0017-0","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T08:49:12Z","timestamp":1520930952000},"page":"167-171","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis"],"prefix":"10.1038","volume":"20","author":[{"given":"Laura","family":"Watts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugce","family":"Karaderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amity","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wordsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Wordsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Vecellio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1002\/art.21492","volume":"52","author":"N Akkoc","year":"2005","unstructured":"Akkoc N, Khan MA. Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al. Arthritis Rheum. 2005;52:4048\u20139.","journal-title":"Arthritis Rheum"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730\u20138.","journal-title":"Nat Genet"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, Han B, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48:510\u20138.","journal-title":"Nat Genet"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/acr.22730","volume":"68","author":"JD Castillo-Ortiz","year":"2016","unstructured":"Castillo-Ortiz JD, Ramiro S, Landew\u00e9 R, van der Heijde D, Dougados M, van den Bosch F, et al. Work outcome in patients with ankylosing spondylitis: results from a 12-year follow up of an international study. Arthritis Care Res. 2016;68:544\u201352.","journal-title":"Arthritis Care Res"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70:1921\u20135.","journal-title":"Ann Rheum Dis"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/annrheumdis-2013-204835","volume":"74","author":"A Cortes","year":"2015","unstructured":"Cortes A, Maksymowych WP, Wordsworth BP, Inman RD, Danoy P, Rahman P, et al. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Ann Rheum Dis. 2015;74:1387\u201393.","journal-title":"Ann Rheum Dis"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1002\/art.11106","volume":"48","author":"MA Brown","year":"2003","unstructured":"Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, et al. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum. 2003;48:2234\u20139.","journal-title":"Arthritis Rheum"},{"key":"17_CR8","first-page":"cd005468","volume":"4","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015;4:cd005468.","journal-title":"Cochrane Database Syst Rev"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20090","volume":"20","author":"M Corbett","year":"2016","unstructured":"Corbett M, Soares M, Jhuti G, Rice S, Spackman E, Sideris E, et al. Tumour necrosis factor-\u03b1 inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation. Health Technol Assess. 2016;20:1\u2013334.","journal-title":"Health Technol Assess"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3109\/s10165-012-0699-5","volume":"23","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, Duan Z, Zhang T, Wang S, Li G, Gao J, et al. Association between tumor necrosis factor-alpha (TNF-alpha) promoter \u2212308 G\/A and response to TNF-alpha blockers in rheumatoid arthritis: a meta-analysis. Mod Rheumatol. 2013;23:489\u201395.","journal-title":"Mod Rheumatol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2015.05.049","volume":"28","author":"W Chen","year":"2015","unstructured":"Chen W, Xu H, Wang X, Gu J, Xiong H, Shi Y. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis. Int Immunopharmacol. 2015;28:146\u201353.","journal-title":"Int Immunopharmacol"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","volume":"50","author":"HT Idriss","year":"2000","unstructured":"Idriss HT, Naismith JH. TNF-alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Technol. 2000;50:184\u201395.","journal-title":"Microsc Res Technol"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/ard.2010.133322","volume":"70","author":"SI Davidson","year":"2011","unstructured":"Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, et al. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2011;70:289\u201392.","journal-title":"Ann Rheum Dis"},{"key":"17_CR14","first-page":"110","volume":"30","author":"T Karaderi","year":"2012","unstructured":"Karaderi T, Pointon JJ, Wordsworth TW, Harvey D, Appleton LH, Cohen CJ, et al. Evidence of genetic association between TNFRSF1A encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK Caucasians. Clin Exp Rheumatol. 2012;30:110\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11307","volume":"488","author":"AP Gregory","year":"2012","unstructured":"Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 2012;488:508\u201311.","journal-title":"Nature"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2012","unstructured":"Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2012;476:214\u20139.","journal-title":"Nature"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1212\/WNL.53.3.457","volume":"53","author":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group.","year":"1999","unstructured":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology. 1999;53:457\u201365.","journal-title":"Neurology"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1212\/WNL.0b013e318294b2d6","volume":"80","author":"M Comabella","year":"2013","unstructured":"Comabella M, Caminero AB, Malhotra S, Agullo L, Fernandez O, Reverter F, et al. TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis. Neurology. 2013;80:2010\u20136.","journal-title":"Neurology"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1212\/01.wnl.0000436612.66328.8a","volume":"81","author":"L Ottoboni","year":"2013","unstructured":"Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, et al. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 2013;81:1891\u20139.","journal-title":"Neurology"},{"key":"17_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075416","volume":"8","author":"EM Mowry","year":"2013","unstructured":"Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, et al. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS ONE. 2013;8:e75416.","journal-title":"PLoS ONE"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","volume":"44","author":"A Keat","year":"2005","unstructured":"Keat A, Barkham N, Bhalla A, Gaffney K, Marzo-Ortega H, Paul S, et al. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for. Rheumatol Rheumatol. 2005;44:939\u201347.","journal-title":"Rheumatol Rheumatol"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden Van der","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383.","journal-title":"Ann Rheum Dis"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jbspin.2006.11.003","volume":"74","author":"J Freeston","year":"2007","unstructured":"Freeston J, Barkham N, Hensor E, Emery P, Fraser A. Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies. J Bone Spine. 2007;74:140\u20133.","journal-title":"J Bone Spine"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10067-010-1581-5","volume":"30","author":"E Roussou","year":"2011","unstructured":"Roussou E, Sultana S. Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis disease activity and functional indices (BASDAI and BASFI) between men and women with spondyloarthritides. Clin Rheumatol. 2011;30:121\u20137.","journal-title":"Clin Rheumatol"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/1529-0131(199806)41:6<1119::AID-ART20>3.0.CO;2-0","volume":"41","author":"AL Taylor","year":"1998","unstructured":"Taylor AL, Balakrishnan C, Calin A. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum. 1998;41:1119\u201325.","journal-title":"Arthritis Rheum"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0017-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:54Z","timestamp":1684617294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-018-0017-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1038\/s41435-018-0017-0","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}